Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia K Sun, Y Zhang, A D’Alessandro, T Nemkov, A Song, H Wu, H Liu, ... Nature communications 7 (1), 12086, 2016 | 194 | 2016 |
Sex-associated molecular differences for cancer immunotherapy Y Ye, Y Jing, L Li, GB Mills, L Diao, H Liu, L Han Nature communications 11 (1), 1779, 2020 | 177 | 2020 |
ADORA1 inhibition promotes tumor immune evasion by regulating the ATF3-PD-L1 axis H Liu, X Kuang, Y Zhang, Y Ye, J Li, L Liang, Z Xie, L Weng, J Guo, H Li, ... Cancer cell 37 (3), 324-339. e8, 2020 | 139 | 2020 |
Beneficial role of erythrocyte adenosine A2B receptor–Mediated AMP-activated Protein Kinase activation in high-altitude hypoxia H Liu, Y Zhang, H Wu, A D’Alessandro, GG Yegutkin, A Song, K Sun, J Li, ... Circulation 134 (5), 405-421, 2016 | 134 | 2016 |
AltitudeOmics: red blood cell metabolic adaptation to high altitude hypoxia A d’Alessandro, T Nemkov, K Sun, H Liu, A Song, AA Monte, AW Subudhi, ... Journal of proteome research 15 (10), 3883-3895, 2016 | 119 | 2016 |
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics S Zhu, Y Guo, X Zhang, H Liu, M Yin, X Chen, C Peng Cancer letters 503, 240-248, 2021 | 116 | 2021 |
Ototoxic effects and mechanisms of loop diuretics D Ding, H Liu, W Qi, H Jiang, Y Li, X Wu, H Sun, K Gross, R Salvi Journal of otology 11 (4), 145-156, 2016 | 107 | 2016 |
Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1 Y Ye, X Kuang, Z Xie, L Liang, Z Zhang, Y Zhang, F Ma, Q Gao, R Chang, ... Genome medicine 12, 1-19, 2020 | 99 | 2020 |
Beneficial and detrimental role of adenosine signaling in diseases and therapy H Liu, Y Xia Journal of applied physiology 119 (10), 1173-1182, 2015 | 98 | 2015 |
Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent A Song, Y Zhang, L Han, GG Yegutkin, H Liu, K Sun, A D’Alessandro, J Li, ... Nature communications 8 (1), 14108, 2017 | 87 | 2017 |
Hypoxia-mediated impaired erythrocyte Lands’ Cycle is pathogenic for sickle cell disease H Wu, M Bogdanov, Y Zhang, K Sun, S Zhao, A Song, R Luo, NF Parchim, ... Scientific reports 6 (1), 29637, 2016 | 70 | 2016 |
Association between sex and immune-related adverse events during immune checkpoint inhibitor therapy Y Jing, Y Zhang, J Wang, K Li, X Chen, J Heng, Q Gao, Y Ye, Z Zhang, ... JNCI: Journal of the National Cancer Institute 113 (10), 1396-1404, 2021 | 67 | 2021 |
Structural and functional insight of sphingosine 1-phosphate-mediated pathogenic metabolic reprogramming in sickle cell disease K Sun, A D’Alessandro, MH Ahmed, Y Zhang, A Song, TP Ko, T Nemkov, ... Scientific reports 7 (1), 15281, 2017 | 67 | 2017 |
Sustained elevated adenosine via ADORA2B promotes chronic pain through neuro-immune interaction X Hu, MG Adebiyi, J Luo, K Sun, TTT Le, Y Zhang, H Wu, S Zhao, ... Cell Reports 16 (1), 106-119, 2016 | 64 | 2016 |
Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization N Liu, JL Zhang, M Yin, H Liu, X Zhang, J Li, B Yan, Y Guo, J Zhou, J Tao, ... Molecular Therapy 29 (7), 2321-2334, 2021 | 57 | 2021 |
Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis F Luo, NB Le, T Mills, NY Chen, H Karmouty-Quintana, JG Molina, ... The FASEB Journal 30 (2), 874, 2016 | 44 | 2016 |
Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy Y Jing, X Chen, K Li, Y Liu, Z Zhang, Y Chen, Y Liu, Y Wang, SH Lin, ... Journal for immunotherapy of cancer 10 (1), 2022 | 42 | 2022 |
The beneficial role of sunitinib in tumor immune surveillance by regulating tumor PD‐L1 H Li, X Kuang, L Liang, Y Ye, YC Zhang, J Li, F Ma, J Tao, G Lei, S Zhao, ... Advanced Science 8 (2), 2001596, 2021 | 42 | 2021 |
Potent USP10/13 antagonist spautin‐1 suppresses melanoma growth via ROS‐mediated DNA damage and exhibits synergy with cisplatin J Guo, JL Zhang, L Liang, N Liu, M Qi, S Zhao, J Su, J Liu, C Peng, ... Journal of Cellular and Molecular Medicine 24 (7), 4324-4340, 2020 | 36 | 2020 |
Role of purines in regulation of metabolic reprogramming Z Tang, W Ye, H Chen, X Kuang, J Guo, M Xiang, C Peng, X Chen, H Liu Purinergic signalling 15, 423-438, 2019 | 36 | 2019 |